Search
for
Sort by
Research 301–330 of 525
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Alopecia areata
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Skin Pigmentation Types, Causes and Treatment—A Review
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Alopecia areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Advances in the mechanism and new therapies of alopecia areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- The Sebaceous Gland - Friend or Foe?
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Alopecia areata – Aktuelles Verständnis und Management